1-nitrosocyclohexyl-acetate has been researched along with Heart-Failure* in 1 studies
1 other study(ies) available for 1-nitrosocyclohexyl-acetate and Heart-Failure
Article | Year |
---|---|
Nitroxyl-mediated disulfide bond formation between cardiac myofilament cysteines enhances contractile function.
In the myocardium, redox/cysteine modification of proteins regulating Ca(2+) cycling can affect contraction and may have therapeutic value. Nitroxyl (HNO), the one-electron-reduced form of nitric oxide, enhances cardiac function in a manner that suggests reversible cysteine modifications of the contractile machinery.. To determine the effects of HNO modification in cardiac myofilament proteins.. The HNO-donor, 1-nitrosocyclohexyl acetate, was found to act directly on the myofilament proteins, increasing maximum force (F(max)) and reducing the concentration of Ca(2+) for 50% activation (Ca(50)) in intact and skinned cardiac muscles. The effects of 1-nitrosocyclohexyl acetate are reversible by reducing agents and distinct from those of another HNO donor, Angeli salt, which was previously reported to increase F(max) without affecting Ca50. Using a new mass spectrometry capture technique based on the biotin switch assay, we identified and characterized the formation by HNO of a disulfide-linked actin-tropomyosin and myosin heavy chain-myosin light chain 1. Comparison of the 1-nitrosocyclohexyl acetate and Angeli salt effects with the modifications induced by each donor indicated the actin-tropomyosin and myosin heavy chain-myosin light chain 1 interactions independently correlated with increased Ca(2+) sensitivity and force generation, respectively.. HNO exerts a direct effect on cardiac myofilament proteins increasing myofilament Ca(2+) responsiveness by promoting disulfide bond formation between critical cysteine residues. These findings indicate a novel, redox-based modulation of the contractile apparatus, which positively impacts myocardial function, providing further mechanistic insight for HNO as a therapeutic agent. Topics: Acetates; Actins; Animals; Calcium; Cysteine; Dimerization; Disulfides; Heart Failure; In Vitro Techniques; Muscle Fibers, Skeletal; Muscle Proteins; Myocardial Contraction; Myocytes, Cardiac; Myofibrils; Myosin Light Chains; Nitric Oxide; Nitrogen Oxides; Nitroso Compounds; Oxidation-Reduction; Rats | 2012 |